These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32508657)

  • 1. Troponins and Natriuretic Peptides in Cardio-Oncology Patients-Data From the ECoR Registry.
    Hinrichs L; Mrotzek SM; Mincu RI; Pohl J; Röll A; Michel L; Mahabadi AA; Al-Rashid F; Totzeck M; Rassaf T
    Front Pharmacol; 2020; 11():740. PubMed ID: 32508657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Cardiomyopathy Risk Prediction Using Global Longitudinal Strain and N-Terminal-Pro-B-Type Natriuretic Peptide in Survivors of Childhood Cancer Exposed to Cardiotoxic Therapy.
    Ehrhardt MJ; Liu Q; Mulrooney DA; Rhea IB; Dixon SB; Lucas JT; Sapkota Y; Shelton K; Ness KK; Srivastava DK; McDonald A; Robison LL; Hudson MM; Yasui Y; Armstrong GT
    J Clin Oncol; 2024 Apr; 42(11):1265-1277. PubMed ID: 38207238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relation Between Global Longitudinal Strain and Serum Natriuretic Peptide Is More Strict Than That Found Between the Latter and Left Ventricular Ejection Fraction: A Retrospective Study in Chronic Heart Failure.
    De Vecchis R; Baldi C; Di Biase G
    J Clin Med Res; 2015 Dec; 7(12):979-88. PubMed ID: 26566412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global left ventricular longitudinal strain is closely associated with increased neurohormonal activation after acute myocardial infarction in patients with both reduced and preserved ejection fraction: a two-dimensional speckle tracking study.
    Ersbøll M; Valeur N; Mogensen UM; Andersen M; Greibe R; Møller JE; Hassager C; Søgaard P; Køber L
    Eur J Heart Fail; 2012 Oct; 14(10):1121-9. PubMed ID: 22753861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab.
    Bouwer NI; Liesting C; Kofflard MJM; Sprangers-van Campen SM; Brugts JJ; Kitzen JJEM; Fouraux MA; Levin MD; Boersma E
    Cardiooncology; 2019; 5():4. PubMed ID: 32154011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of early phrase echocardiography and cardiac biological markers in patients with severe sepsis: a five-year single-center retrospective study].
    Zang X; Chen W; Sheng B; Zhao L; Gu X; Zhen J; Liu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Apr; 30(4):332-336. PubMed ID: 29663994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
    Čiburienė E; Aidietienė S; Ščerbickaitė G; Sadauskienė E; Sudavičienė D; Baltruškevičienė E; Brasiūnienė B; Drobnienė M; Čelutkienė J
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138243
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial.
    Rüger AM; Schneeweiss A; Seiler S; Tesch H; van Mackelenbergh M; Marmé F; Lübbe K; Sinn B; Karn T; Stickeler E; Müller V; Schem C; Denkert C; Fasching PA; Nekljudova V; Garfias-Macedo T; Hasenfuß G; Haverkamp W; Loibl S; von Haehling S
    J Am Heart Assoc; 2020 Dec; 9(23):e018143. PubMed ID: 33191846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
    Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
    Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines.
    Bhagat AA; Kalogeropoulos AP; Baer L; Lacey M; Kort S; Skopicki HA; Butler J; Bloom MW
    J Pers Med; 2023 Dec; 13(12):. PubMed ID: 38138937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
    Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
    Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP Concentration and Early Cardiac Dysfunction in Patients Receiving Dialysis: A Prospective Cohort Study.
    Yang WL; Hawley C; Cho Y; Johnson DW; Pascoe EM; Fahim M;
    Cardiorenal Med; 2020; 10(5):323-332. PubMed ID: 32460295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patients.
    Eriguchi M; Tsuruya K; Lopes M; Bieber B; McCullough K; Pecoits-Filho R; Robinson B; Pisoni R; Kanda E; Iseki K; Hirakata H
    ESC Heart Fail; 2022 Apr; 9(2):1138-1151. PubMed ID: 35026869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
    Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
    Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study.
    Rosenkaimer SL; Winter L; Sieburg T; Maier S; Mavratzas A; Hofmann WK; Akin I; Duerschmied D; Hofheinz RD; Hohneck A
    Oncol Res Treat; 2022; 45(10):598-607. PubMed ID: 35764064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction.
    Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B
    J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Diastolic Dysfunction after Cancer Chemotherapy: Primary Endpoint Results of a Multicenter Cardio-Oncology Study.
    Calabrese V; Menna P; Annibali O; Armento G; Carpino A; Cerchiara E; Greco C; Marchesi F; Spallarossa P; Toglia G; Reggiardo G; Minotti G;
    Chemotherapy; 2018; 63(2):55-63. PubMed ID: 29428939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of N-terminal pro-B-type natriuretic peptide (NT-ProBNP) as a marker for cardiotoxicity and comparison with echocardiography in paediatric carbon monoxide poisoning.
    Turan C; Dogan E; Yurtseven A; Saz EU
    Cardiol Young; 2020 Aug; 30(8):1103-1108. PubMed ID: 32571446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Predictive Value of NT-proBNP Combined With Echocardiography in Anthracyclines Induced Cardiotoxicity.
    Dong Y; Wu Q; Hu C
    Front Surg; 2022; 9():898172. PubMed ID: 35846969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.